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Objectives:Data on the influence of contralateral carotid
occlusion (CCO) on carotid endarterectomy (CEA) are con-
flicting and are absent for carotid stenting (CAS). This study
evaluated the influence of CCO on CEA and CAS.
Methods: We evaluated patients (pts) with and without
CCO in the SVS Vascular Registry. Primary outcome was a
composite of periprocedural death, stroke, or MI (MACE)
and its individual components. Further analysis was done to
identify the influence, if any of symptom status on outcomes.
Results: There were 1128 CAS and 666 CEA pts with
CCO. CAS pts were more often symptomatic with a higher
incidence of coronary artery disease, congestive heart fail-
ure, diabetes, COPD, and NYHA 3. Absolute risk of
periprocedural MACE (2.75% CAS v. 4.20% CEA), death
(1.06% CAS v. 0.75% CEA), stroke (2.13% CAS v 3.15%
CEA), and MI (CAS 0.35% v 0.60% CEA) was statistically
equivalent for both. This equivalence was maintained when
pts with CCOwere segregated by symptom status and after
adjusting for perioprocedural risk. There were 16,646 pts
without contralateral occlusion (NCO) (5698 CAS;
10,948 CEA). NCO pts with CEA have better outcomes in
periprocedural MACE (1.76% NCO vs 4.20% CCO), and
stroke (1.06% NCO vs 3.15% CCO) (P .0001 for both).
In CAS pts, CCO did not significantly affect periprocedural
MACE (3.16%NCO vs 2.75% CCO), death (0.8%NCO vs
1.0% CCO), stroke (2.3%NCO vs 2.1% CCO) orMI (0.6%
vs. NCO s 0.3% CCO). In CEA pts, CCO increased
MACE, primarily by increasing stroke rates in both asymp-
tomatic (0.68 % vs. 2.00%, P  .0095) and symptomatic
(1.68% vs 4.89%, P  .0012) pts.
Conclusions: While CEA is preferred in NCO pts,
regardless of symptom status, based on lower perioproce-
dural MACE, death and stroke, the benefit of CEA is lost in
pts with CCO because of increased stroke rates in CCO pts
after CEA but not CAS regardless of symptom status. The
results of CAS and CEA in patients with CCO are equiva-
lent and within acceptable AHA guidelines.
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Objectives: While carotid endarterectomy (CEA) is
performed to prevent stroke, long-term survival is essential
to ensure benefit, especially in asymptomatic patients. We
examined patient factors associated with 5-year survival
following CEA in patients with asymptomatic internal ca-
rotid artery (ICA) stenosis.
Methods: Prospectively collected data from 4,294 iso-
lated CEAs performed for asymptomatic stenosis across 24
centers in the Vascular Study Group of New England
(VSGNE) between 2003-2011 were used for this analysis.
Mortality was determined from the Social Security Death
Index. Cox proportional hazard models were used to iden-
tify risk factors for mortality within the first 5 years after
CEA.
Results: Overall 5-year survival was 82%. In multivari-
ate analysis, increasing strata of age, diabetes, smoking
history, congestive heart failure (CHF), COPD, poor renal
function (eGFR60 or dialysis dependence), and degree of
contralateral ICA stenosis were all associated with worse
survival, while statin use predicted improved survival. Pa-
tients classified as low (52%), medium (36%) and high risk
(12%) based on number of risk factors had 5-year survival
rates of 93%, 85% and 57% respectively (P .001, Fig).
Conclusions: More than four out of five asymptomatic
patients selected for CEA in the VSGNE achieved 5-year
survival, demonstrating appropriate patient selection in our
region. However, there are patients with high risk profiles,
based on the above risk factors, who are unlikely to survive
long enough to realize a benefit of CEA for asymptomatic
stenosis. Predicting survival is important for decision mak-
ing in these patients.
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